Adial Pharmaceuticals WT Alpha and Beta Analysis
ADILWDelisted Stock | USD 0.01 0 52.50% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Adial Pharmaceuticals WT. It also helps investors analyze the systematic and unsystematic risks associated with investing in Adial Pharmaceuticals over a specified time horizon. Remember, high Adial Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Adial Pharmaceuticals' market risk premium analysis include:
Beta (0.99) | Alpha 4.02 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Adial |
Adial Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Adial Pharmaceuticals market risk premium is the additional return an investor will receive from holding Adial Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Adial Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Adial Pharmaceuticals' performance over market.α | 4.02 | β | -0.99 |
Adial Pharmaceuticals Fundamentals Vs Peers
Comparing Adial Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Adial Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Adial Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Adial Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Adial Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Adial Pharmaceuticals by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Adial Pharmaceuticals to competition |
Fundamentals | Adial Pharmaceuticals | Peer Average |
Number Of Shares Shorted | 506 | 4.71 M |
EBITDA | (13.78 M) | 3.9 B |
Net Income | (12.73 M) | 570.98 M |
Total Debt | 207.38 K | 5.32 B |
Cash Flow From Operations | (11.19 M) | 971.22 M |
Total Asset | 5.73 M | 29.47 B |
Retained Earnings | (63.67 M) | 9.33 B |
Adial Pharmaceuticals Opportunities
Adial Pharmaceuticals Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
Timeline |
1 | ADIAL PHARMACEUTICALS, INC. Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits - Marketscreen... | 06/02/2023 |
About Adial Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Adial or other delisted stocks. Alpha measures the amount that position in Adial Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adial Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adial Pharmaceuticals' short interest history, or implied volatility extrapolated from Adial Pharmaceuticals options trading.
Build Portfolio with Adial Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Adial Stock
If you are still planning to invest in Adial Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adial Pharmaceuticals' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |